Concepts (138)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
Lymphocytosis | 3 | 2018 | 122 | 1.53 | Why? |
Graft Survival | 3 | 2018 | 587 | 1.30 | Why? |
Kidney Transplantation | 6 | 2020 | 5397 | 0.95 | Why? |
Arteriovenous Shunt, Surgical | 2 | 2017 | 93 | 0.80 | Why? |
Nephritis, Interstitial | 1 | 2020 | 83 | 0.78 | Why? |
Glycolipids | 1 | 2018 | 19 | 0.73 | Why? |
alpha-Galactosidase | 1 | 2018 | 32 | 0.72 | Why? |
HIV Seronegativity | 1 | 2018 | 112 | 0.72 | Why? |
Lupus Nephritis | 1 | 2018 | 113 | 0.69 | Why? |
Sphingolipids | 1 | 2018 | 59 | 0.68 | Why? |
Oscillometry | 1 | 2017 | 50 | 0.68 | Why? |
Monoclonal Gammopathy of Undetermined Significance | 1 | 2017 | 57 | 0.67 | Why? |
Immunophenotyping | 2 | 2018 | 1290 | 0.65 | Why? |
Precancerous Conditions | 1 | 2017 | 108 | 0.64 | Why? |
Fabry Disease | 1 | 2018 | 106 | 0.64 | Why? |
Renal Dialysis | 6 | 2021 | 4358 | 0.55 | Why? |
Fingers | 1 | 2017 | 221 | 0.55 | Why? |
Genetic Testing | 1 | 2018 | 395 | 0.55 | Why? |
Kidney Failure, Chronic | 3 | 2020 | 3222 | 0.55 | Why? |
Blood Pressure Monitoring, Ambulatory | 1 | 2017 | 341 | 0.53 | Why? |
Graft Rejection | 2 | 2018 | 1766 | 0.43 | Why? |
Immunosuppressive Agents | 2 | 2020 | 6331 | 0.43 | Why? |
Leukemia, Lymphocytic, Chronic, B-Cell | 1 | 2018 | 877 | 0.42 | Why? |
Renal Replacement Therapy | 1 | 2018 | 1530 | 0.37 | Why? |
Antibodies, Monoclonal, Humanized | 2 | 2020 | 9335 | 0.34 | Why? |
B-Lymphocytes | 2 | 2018 | 4418 | 0.32 | Why? |
Renal Insufficiency, Chronic | 2 | 2017 | 2654 | 0.30 | Why? |
Acid-Base Imbalance | 1 | 2021 | 46 | 0.22 | Why? |
Genetic Carrier Screening | 1 | 2018 | 18 | 0.19 | Why? |
Hypokalemia | 1 | 2021 | 195 | 0.18 | Why? |
Polycystic Kidney, Autosomal Dominant | 1 | 2018 | 31 | 0.18 | Why? |
Diabetic Neuropathies | 1 | 2017 | 64 | 0.16 | Why? |
Herpesvirus 8, Human | 1 | 2017 | 97 | 0.16 | Why? |
Brachial Artery | 1 | 2017 | 107 | 0.16 | Why? |
Cyclophosphamide | 1 | 2018 | 387 | 0.16 | Why? |
Regional Blood Flow | 1 | 2017 | 172 | 0.16 | Why? |
Systole | 1 | 2017 | 252 | 0.16 | Why? |
Kidney Function Tests | 1 | 2018 | 520 | 0.15 | Why? |
Hydroxychloroquine | 1 | 2020 | 12447 | 0.15 | Why? |
Herpesviridae Infections | 1 | 2017 | 172 | 0.15 | Why? |
Eligibility Determination | 1 | 2017 | 255 | 0.15 | Why? |
Glomerular Filtration Rate | 2 | 2018 | 1262 | 0.15 | Why? |
DNA Mutational Analysis | 1 | 2018 | 581 | 0.15 | Why? |
Physicians, Primary Care | 1 | 2018 | 298 | 0.14 | Why? |
Blood Pressure Determination | 1 | 2017 | 450 | 0.13 | Why? |
Outpatient Clinics, Hospital | 1 | 2018 | 523 | 0.13 | Why? |
Blood Vessel Prosthesis Implantation | 1 | 2016 | 226 | 0.13 | Why? |
CD4 Lymphocyte Count | 1 | 2018 | 1517 | 0.12 | Why? |
Antiretroviral Therapy, Highly Active | 1 | 2018 | 952 | 0.12 | Why? |
HIV Infections | 1 | 2018 | 11620 | 0.12 | Why? |
Mutation, Missense | 1 | 2018 | 863 | 0.12 | Why? |
Treatment Outcome | 4 | 2020 | 51732 | 0.11 | Why? |
Education, Medical, Continuing | 1 | 2018 | 638 | 0.11 | Why? |
Treatment Failure | 1 | 2017 | 2106 | 0.11 | Why? |
Catheterization, Central Venous | 1 | 2016 | 458 | 0.11 | Why? |
Renal Insufficiency | 1 | 2018 | 810 | 0.11 | Why? |
Transplant Recipients | 2 | 2018 | 4982 | 0.11 | Why? |
Middle Aged | 13 | 2021 | 270681 | 0.11 | Why? |
Amino Acid Substitution | 1 | 2018 | 1706 | 0.11 | Why? |
Italy | 7 | 2021 | 38444 | 0.11 | Why? |
Prevalence | 5 | 2021 | 25773 | 0.10 | Why? |
Nephrology | 1 | 2016 | 546 | 0.10 | Why? |
Decision Support Techniques | 1 | 2017 | 903 | 0.10 | Why? |
Postoperative Complications | 2 | 2018 | 5861 | 0.10 | Why? |
Male | 14 | 2021 | 367725 | 0.09 | Why? |
Risk Factors | 6 | 2021 | 71621 | 0.09 | Why? |
Female | 13 | 2021 | 380317 | 0.09 | Why? |
Kaplan-Meier Estimate | 1 | 2017 | 4260 | 0.09 | Why? |
Multiple Myeloma | 1 | 2017 | 1064 | 0.09 | Why? |
Delayed Diagnosis | 1 | 2018 | 1529 | 0.09 | Why? |
Tissue Donors | 1 | 2017 | 1679 | 0.09 | Why? |
Aged | 12 | 2021 | 215776 | 0.09 | Why? |
Prognosis | 3 | 2021 | 32490 | 0.08 | Why? |
Proteinuria | 2 | 2021 | 474 | 0.08 | Why? |
Retrospective Studies | 6 | 2021 | 105322 | 0.08 | Why? |
Time Factors | 3 | 2018 | 31397 | 0.08 | Why? |
Humans | 20 | 2021 | 930598 | 0.07 | Why? |
Blood Pressure | 1 | 2017 | 2198 | 0.07 | Why? |
Health Promotion | 1 | 2018 | 2020 | 0.07 | Why? |
Renin-Angiotensin System | 1 | 2020 | 3661 | 0.07 | Why? |
Incidence | 4 | 2021 | 25622 | 0.07 | Why? |
Outpatients | 1 | 2017 | 3417 | 0.07 | Why? |
Clinical Decision-Making | 1 | 2017 | 3755 | 0.06 | Why? |
Patient Care Team | 1 | 2017 | 3556 | 0.06 | Why? |
Follow-Up Studies | 2 | 2018 | 17020 | 0.06 | Why? |
Patient Selection | 1 | 2017 | 4560 | 0.06 | Why? |
Adult | 7 | 2021 | 244371 | 0.06 | Why? |
Predictive Value of Tests | 1 | 2017 | 9537 | 0.06 | Why? |
Organ Transplantation | 1 | 2017 | 2616 | 0.06 | Why? |
Acute Kidney Injury | 1 | 2021 | 5762 | 0.05 | Why? |
Enzyme Induction | 1 | 2020 | 89 | 0.05 | Why? |
Reproducibility of Results | 1 | 2017 | 11304 | 0.05 | Why? |
Hematuria | 1 | 2021 | 284 | 0.05 | Why? |
Risk Assessment | 2 | 2021 | 25439 | 0.05 | Why? |
Diuretics | 1 | 2021 | 326 | 0.05 | Why? |
Aged, 80 and over | 5 | 2021 | 88759 | 0.05 | Why? |
Disease Progression | 1 | 2017 | 13580 | 0.05 | Why? |
Healthcare Disparities | 1 | 2016 | 3893 | 0.04 | Why? |
Registries | 1 | 2018 | 12327 | 0.04 | Why? |
Angiotensin I | 1 | 2020 | 200 | 0.04 | Why? |
Potassium | 1 | 2021 | 325 | 0.04 | Why? |
Practice Patterns, Physicians' | 1 | 2016 | 4927 | 0.04 | Why? |
Blood Gas Analysis | 1 | 2021 | 893 | 0.04 | Why? |
Viral Load | 1 | 2018 | 15850 | 0.04 | Why? |
Prospective Studies | 2 | 2018 | 43301 | 0.04 | Why? |
Organ Specificity | 1 | 2020 | 1070 | 0.04 | Why? |
Comorbidity | 1 | 2020 | 34796 | 0.04 | Why? |
Respiration, Artificial | 1 | 2020 | 22116 | 0.04 | Why? |
Diabetic Nephropathies | 1 | 2018 | 315 | 0.03 | Why? |
Angiotensin II | 1 | 2020 | 601 | 0.03 | Why? |
Down-Regulation | 1 | 2020 | 1416 | 0.03 | Why? |
Pneumonia, Viral | 1 | 2020 | 243684 | 0.03 | Why? |
Frail Elderly | 1 | 2021 | 1427 | 0.03 | Why? |
Coronavirus Infections | 1 | 2020 | 253789 | 0.03 | Why? |
Program Evaluation | 1 | 2018 | 1929 | 0.03 | Why? |
Antibodies, Viral | 2 | 2021 | 51949 | 0.02 | Why? |
Adolescent | 1 | 2018 | 86841 | 0.02 | Why? |
Antihypertensive Agents | 1 | 2020 | 1962 | 0.02 | Why? |
Antiviral Agents | 1 | 2020 | 41703 | 0.02 | Why? |
Immunity, Humoral | 1 | 2021 | 4849 | 0.02 | Why? |
Survival Rate | 1 | 2021 | 9206 | 0.02 | Why? |
Health Care Surveys | 1 | 2016 | 2942 | 0.02 | Why? |
Polymerase Chain Reaction | 1 | 2020 | 6740 | 0.02 | Why? |
Angiotensin Receptor Antagonists | 1 | 2020 | 3892 | 0.02 | Why? |
Pandemics | 2 | 2021 | 389249 | 0.02 | Why? |
Angiotensin-Converting Enzyme Inhibitors | 1 | 2020 | 5277 | 0.01 | Why? |
Virus Internalization | 1 | 2020 | 7921 | 0.01 | Why? |
Europe | 1 | 2018 | 12702 | 0.01 | Why? |
Host-Pathogen Interactions | 1 | 2020 | 11041 | 0.01 | Why? |
Hypertension | 1 | 2020 | 8895 | 0.01 | Why? |
Hospital Mortality | 1 | 2021 | 22087 | 0.01 | Why? |
Betacoronavirus | 1 | 2020 | 204454 | 0.01 | Why? |
Cohort Studies | 1 | 2018 | 36005 | 0.01 | Why? |
Child | 1 | 2021 | 70012 | 0.01 | Why? |
Lung | 1 | 2020 | 31049 | 0.01 | Why? |
Animals | 1 | 2020 | 78931 | 0.01 | Why? |
Hospitalization | 1 | 2021 | 54280 | 0.01 | Why? |
Young Adult | 1 | 2017 | 93724 | 0.00 | Why? |
Cappelli's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(138)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(58)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_